Het gebruik van laag moleculair gewicht heparines (LMGH) tijdens hemodialyse.
Phase 1
- Conditions
- Chronisch nierfalen met dialysenood
- Registration Number
- EUCTR2008-005224-91-BE
- Lead Sponsor
- niversity Hospital Ghent
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Leeftijd > 18 jaar
Chronic kidney disease (CKD) stadium 5 waarvoor chronische hemodiafiltratie of hemodialyse
Hematocriet > 30%
Tekenen van informed consent
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Behandeling met vitamine K antagonisten
Behandeling met andere heparines dan deze gebruikt tijdens dialyse
Thrombopenie < 120.000 /µl
Actieve bloeding
Allergie op heparine
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method